Skip to content

Clinical trials

Thrombocytopenia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: Canada Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20082
20093
20102
20111
20123
20134
20143
20161
20171
20191
20201
20211
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Recruiting3
Active, not recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Novartis Pharmaceuticals4
Amgen3
Eisai Inc.2
McMaster University2
Abbott Medical Devices1
Alnylam Pharmaceuticals1
Archemix Corp.1
Boston Children's Hospital1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia32
Purpura, Thrombocytopenic, Idiopathic9
Hemorrhage5
Myelodysplastic Syndromes5
Purpura4
Anemia3
Hematologic Diseases3
Leukemia, Myeloid, Acute3
Myeloproliferative Disorders3
Hemorrhagic Disorders2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.